Watson Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?
WATSON LABS INC has seventy-five approved drugs.
There are eleven tentative approvals on WATSON LABS INC drugs.
Drugs and US Patents for Watson Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Inc | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 208107-001 | Dec 6, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062816-001 | Oct 24, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs Inc | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 077455-001 | Jul 19, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs Inc | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SUPPOSITORY;RECTAL | 040479-002 | Jun 24, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-005 | Oct 26, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs Inc | CELECOXIB | celecoxib | CAPSULE;ORAL | 200562-004 | Feb 11, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs Inc | CELECOXIB | celecoxib | CAPSULE;ORAL | 200562-001 | Feb 11, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.